Prognostic value of PAI1 in invasive breast cancer: Evidence that tumor-specific factors are more important than genetic variation in regulating PAI1 expression

Mark D. Sternlicht, Alison M. Dunning, Dan H. Moore, Paul D P Pharoah, David G. Ginzinger, Kwang-Yung Chin, Joe Gray, Frederic M. Waldman, Bruce A J Ponder, Zena Werb

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Plasminogen activator inhibitor-1 (PAI1) can promote cancer progression, and its protein expression in tumors is an independent indicator of poor prognosis in many forms of cancer. Here, we show that high PAI1 mRNA levels also predict for shorter overall survival in two independent breast cancer data sets, highlighting the importance of its transcriptional regulation. The -675insG (4G/5G) single-nucleotide polymorphism in the PAI1 gene promoter has been shown to influence PAI1 transcription, with the 4G allele eliciting higher reporter gene expression in vitro and higher levels of circulating PAI1 in vivo. Nevertheless, its genotypic distribution in 2,539 British women with invasive breast cancer was virtually identical to that seen in 1,832 matched controls (P = 0.72), and annual mortality rates for 4G4G, 4G5G, and 5G5G cases were 2.6%, 2.8%, and 3.1% per year, respectively (P = 0.10). Thus, there was no association with breast cancer incidence or outcome, and in a separate set of breast cancers, the 4G/5G single-nucleotide polymorphism showed no association with PAI1 mRNA expression (P = 0.85). By contrast, connective tissue growth factor (CTGF), which can regulate PAI1 expression in culture, was associated with PAI1 expression in three independent cohorts (P ≪ 0.0001). In addition, PAI1 gene copy number differences in the tumors were correlated with PAI1 mRNA expression (P = 0.0005) and seemed to affect expression independently of CTGF. Thus, local factors, such as CTGF and genomic amplification, seem to be more important than germ line genetic variation in influencing PAI1 expression and its untoward effects in breast cancer.

Original languageEnglish (US)
Pages (from-to)2107-2114
Number of pages8
JournalCancer Epidemiology Biomarkers and Prevention
Volume15
Issue number11
DOIs
StatePublished - Nov 2006
Externally publishedYes

Fingerprint

Plasminogen Activator Inhibitor 1
Breast Neoplasms
Neoplasms
Connective Tissue Growth Factor
Messenger RNA
Single Nucleotide Polymorphism
Gene Dosage
Reporter Genes
Germ Cells
Alleles
Gene Expression

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

Prognostic value of PAI1 in invasive breast cancer : Evidence that tumor-specific factors are more important than genetic variation in regulating PAI1 expression. / Sternlicht, Mark D.; Dunning, Alison M.; Moore, Dan H.; Pharoah, Paul D P; Ginzinger, David G.; Chin, Kwang-Yung; Gray, Joe; Waldman, Frederic M.; Ponder, Bruce A J; Werb, Zena.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 15, No. 11, 11.2006, p. 2107-2114.

Research output: Contribution to journalArticle

Sternlicht, Mark D. ; Dunning, Alison M. ; Moore, Dan H. ; Pharoah, Paul D P ; Ginzinger, David G. ; Chin, Kwang-Yung ; Gray, Joe ; Waldman, Frederic M. ; Ponder, Bruce A J ; Werb, Zena. / Prognostic value of PAI1 in invasive breast cancer : Evidence that tumor-specific factors are more important than genetic variation in regulating PAI1 expression. In: Cancer Epidemiology Biomarkers and Prevention. 2006 ; Vol. 15, No. 11. pp. 2107-2114.
@article{7789fa5875e3423aa6d76097a2691412,
title = "Prognostic value of PAI1 in invasive breast cancer: Evidence that tumor-specific factors are more important than genetic variation in regulating PAI1 expression",
abstract = "Plasminogen activator inhibitor-1 (PAI1) can promote cancer progression, and its protein expression in tumors is an independent indicator of poor prognosis in many forms of cancer. Here, we show that high PAI1 mRNA levels also predict for shorter overall survival in two independent breast cancer data sets, highlighting the importance of its transcriptional regulation. The -675insG (4G/5G) single-nucleotide polymorphism in the PAI1 gene promoter has been shown to influence PAI1 transcription, with the 4G allele eliciting higher reporter gene expression in vitro and higher levels of circulating PAI1 in vivo. Nevertheless, its genotypic distribution in 2,539 British women with invasive breast cancer was virtually identical to that seen in 1,832 matched controls (P = 0.72), and annual mortality rates for 4G4G, 4G5G, and 5G5G cases were 2.6{\%}, 2.8{\%}, and 3.1{\%} per year, respectively (P = 0.10). Thus, there was no association with breast cancer incidence or outcome, and in a separate set of breast cancers, the 4G/5G single-nucleotide polymorphism showed no association with PAI1 mRNA expression (P = 0.85). By contrast, connective tissue growth factor (CTGF), which can regulate PAI1 expression in culture, was associated with PAI1 expression in three independent cohorts (P ≪ 0.0001). In addition, PAI1 gene copy number differences in the tumors were correlated with PAI1 mRNA expression (P = 0.0005) and seemed to affect expression independently of CTGF. Thus, local factors, such as CTGF and genomic amplification, seem to be more important than germ line genetic variation in influencing PAI1 expression and its untoward effects in breast cancer.",
author = "Sternlicht, {Mark D.} and Dunning, {Alison M.} and Moore, {Dan H.} and Pharoah, {Paul D P} and Ginzinger, {David G.} and Kwang-Yung Chin and Joe Gray and Waldman, {Frederic M.} and Ponder, {Bruce A J} and Zena Werb",
year = "2006",
month = "11",
doi = "10.1158/1055-9965.EPI-06-0351",
language = "English (US)",
volume = "15",
pages = "2107--2114",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "11",

}

TY - JOUR

T1 - Prognostic value of PAI1 in invasive breast cancer

T2 - Evidence that tumor-specific factors are more important than genetic variation in regulating PAI1 expression

AU - Sternlicht, Mark D.

AU - Dunning, Alison M.

AU - Moore, Dan H.

AU - Pharoah, Paul D P

AU - Ginzinger, David G.

AU - Chin, Kwang-Yung

AU - Gray, Joe

AU - Waldman, Frederic M.

AU - Ponder, Bruce A J

AU - Werb, Zena

PY - 2006/11

Y1 - 2006/11

N2 - Plasminogen activator inhibitor-1 (PAI1) can promote cancer progression, and its protein expression in tumors is an independent indicator of poor prognosis in many forms of cancer. Here, we show that high PAI1 mRNA levels also predict for shorter overall survival in two independent breast cancer data sets, highlighting the importance of its transcriptional regulation. The -675insG (4G/5G) single-nucleotide polymorphism in the PAI1 gene promoter has been shown to influence PAI1 transcription, with the 4G allele eliciting higher reporter gene expression in vitro and higher levels of circulating PAI1 in vivo. Nevertheless, its genotypic distribution in 2,539 British women with invasive breast cancer was virtually identical to that seen in 1,832 matched controls (P = 0.72), and annual mortality rates for 4G4G, 4G5G, and 5G5G cases were 2.6%, 2.8%, and 3.1% per year, respectively (P = 0.10). Thus, there was no association with breast cancer incidence or outcome, and in a separate set of breast cancers, the 4G/5G single-nucleotide polymorphism showed no association with PAI1 mRNA expression (P = 0.85). By contrast, connective tissue growth factor (CTGF), which can regulate PAI1 expression in culture, was associated with PAI1 expression in three independent cohorts (P ≪ 0.0001). In addition, PAI1 gene copy number differences in the tumors were correlated with PAI1 mRNA expression (P = 0.0005) and seemed to affect expression independently of CTGF. Thus, local factors, such as CTGF and genomic amplification, seem to be more important than germ line genetic variation in influencing PAI1 expression and its untoward effects in breast cancer.

AB - Plasminogen activator inhibitor-1 (PAI1) can promote cancer progression, and its protein expression in tumors is an independent indicator of poor prognosis in many forms of cancer. Here, we show that high PAI1 mRNA levels also predict for shorter overall survival in two independent breast cancer data sets, highlighting the importance of its transcriptional regulation. The -675insG (4G/5G) single-nucleotide polymorphism in the PAI1 gene promoter has been shown to influence PAI1 transcription, with the 4G allele eliciting higher reporter gene expression in vitro and higher levels of circulating PAI1 in vivo. Nevertheless, its genotypic distribution in 2,539 British women with invasive breast cancer was virtually identical to that seen in 1,832 matched controls (P = 0.72), and annual mortality rates for 4G4G, 4G5G, and 5G5G cases were 2.6%, 2.8%, and 3.1% per year, respectively (P = 0.10). Thus, there was no association with breast cancer incidence or outcome, and in a separate set of breast cancers, the 4G/5G single-nucleotide polymorphism showed no association with PAI1 mRNA expression (P = 0.85). By contrast, connective tissue growth factor (CTGF), which can regulate PAI1 expression in culture, was associated with PAI1 expression in three independent cohorts (P ≪ 0.0001). In addition, PAI1 gene copy number differences in the tumors were correlated with PAI1 mRNA expression (P = 0.0005) and seemed to affect expression independently of CTGF. Thus, local factors, such as CTGF and genomic amplification, seem to be more important than germ line genetic variation in influencing PAI1 expression and its untoward effects in breast cancer.

UR - http://www.scopus.com/inward/record.url?scp=33845330925&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845330925&partnerID=8YFLogxK

U2 - 10.1158/1055-9965.EPI-06-0351

DO - 10.1158/1055-9965.EPI-06-0351

M3 - Article

C2 - 17119035

AN - SCOPUS:33845330925

VL - 15

SP - 2107

EP - 2114

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 11

ER -